by LaVoie Health Science | Sep 22, 2023 | Blog
Investor relations and social media – two seemingly unrelated entities that, when combined, form a powerful strategy for modern businesses. Much like classic pairings such as peanut butter and jelly, eggs and bacon, or peas and carrots, the fusion of investor...
by Andrew Mahoney | Jul 21, 2023 | Blog
Are there differences in managing communications and strategic communications/investor relations (IR) across all industries? Are the basic skills that you would apply to other industries transferable to health and science industries? The role of the Chief...
by Andrew Mahoney | Jun 30, 2023 | Blog
Artificial Intelligence (AI) has the potential of changing the PR and IR world as we know it today. In the field of biotech, life sciences, and medical technology where effective communication is crucial for disseminating complex information, clinical results,...
by Andrew Mahoney | Jun 14, 2023 | Blog
Building your narrative: How to Tell Your Story in Just 15 Slide Topics is a talk which I have been presenting for more than 15 years now at various conferences including BIO International. While the methodology remains intact, the landscape has changed quite a bit. ...
by Andrew Mahoney | May 11, 2023 | Blog
The H.C. Wainwright BioConnect Investor Conference, hosted by NASDAQ, was a well sought-after day where HCW clients not only had an opportunity to meet with investors, but also to discuss the current market landscape, including drivers and challenges in the health...
by Andrew Mahoney | Mar 17, 2023 | Blog
Last week the LaVoieHealthScience senior management team attended and supported our clients participating at the 43rd Annual TD Cowen Healthcare Conference in Boston – held in person for the first time in three years. Paul Sagan, VP, Investor Relations &...
Recent Comments